======= PIM2 ======= == Gene Information == * **Official Symbol**: PIM2 * **Official Name**: Pim-2 proto-oncogene, serine/threonine kinase * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=11040|11040]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9P1W9|Q9P1W9]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PIM2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PIM2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/300295|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a protooncogene that acts as a serine/threonine protein kinase. Studies determined the encoded protein functions to prevent apoptosis and to promote cell survival.[provided by RefSeq, Nov 2009]. * **UniProt Summary**: Proto-oncogene with serine/threonine kinase activity involved in cell survival and cell proliferation. Exerts its oncogenic activity through: the regulation of MYC transcriptional activity, the regulation of cell cycle progression, the regulation of cap-dependent protein translation and through survival signaling by phosphorylation of a pro-apoptotic protein, BAD. Phosphorylation of MYC leads to an increase of MYC protein stability and thereby an increase transcriptional activity. The stabilization of MYC exerted by PIM2 might explain partly the strong synergism between these 2 oncogenes in tumorigenesis. Regulates cap-dependent protein translation in a mammalian target of rapamycin complex 1 (mTORC1)-independent manner and in parallel to the PI3K-Akt pathway. Mediates survival signaling through phosphorylation of BAD, which induces release of the anti- apoptotic protein Bcl-X(L)/BCL2L1. Promotes cell survival in response to a variety of proliferative signals via positive regulation of the I-kappa-B kinase/NF-kappa-B cascade; this process requires phosphorylation of MAP3K8/COT. Promotes growth factor-independent proliferation by phosphorylation of cell cycle factors such as CDKN1A and CDKN1B. Involved in the positive regulation of chondrocyte survival and autophagy in the epiphyseal growth plate. {ECO:0000269|PubMed:18593906, ECO:0000269|PubMed:18675992, ECO:0000269|PubMed:20307683}. |Pkinase Tyr| |Pkinase| |apoptotic mitochondrial changes| |positive regulation of macroautophagy| |negative regulation of protein binding| |G1/S transition of mitotic cell cycle| |cell cycle G1/S phase transition| |positive regulation of autophagy| |negative regulation of binding| |regulation of macroautophagy| |protein stabilization| |positive regulation of I-kappaB kinase/NF-kappaB signaling| |protein autophosphorylation| |regulation of protein binding| |regulation of I-kappaB kinase/NF-kappaB signaling| |mitotic cell cycle phase transition| |cell cycle phase transition| |response to virus| |regulation of protein stability| |regulation of autophagy| |protein serine/threonine kinase activity| |positive regulation of cellular catabolic process| |regulation of binding| |positive regulation of catabolic process| |mitochondrion organization| |mitotic cell cycle process| |negative regulation of cell population proliferation| |mitotic cell cycle| |regulation of cellular catabolic process| |negative regulation of apoptotic process| |negative regulation of programmed cell death| |apoptotic process| |protein phosphorylation| |regulation of catabolic process| |negative regulation of cell death| |cell cycle process| |positive regulation of intracellular signal transduction| |programmed cell death| |cell death| |negative regulation of molecular function| |phosphorylation| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |cell cycle| |ATP binding| |positive regulation of transcription, DNA-templated| |regulation of apoptotic process| |regulation of programmed cell death| |regulation of cell population proliferation| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |positive regulation of signal transduction| |regulation of cell death| |positive regulation of RNA metabolic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|1.97| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 8/694 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/26| |bone|0/26| |breast|0/30| |central nervous system|0/49| |cervix|0/4| |colorectal|0/17| |esophagus|0/11| |fibroblast|0/1| |gastric|0/14| |kidney|0/18| |liver|0/19| |lung|0/72| |lymphocyte|0/16| |ovary|0/25| |pancreas|0/22| |peripheral nervous system|0/15| |plasma cell|6/12| |prostate|0/1| |skin|0/20| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/28| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 18327 * **Expression level (log2 read counts)**: 4.12 {{:chemogenomics:nalm6 dist.png?nolink |}}